Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Tetra Pharm Logo
Tetra Pharm Growth Score
24
CB Rank
117078
Heat Score
3
Tetra Pharm is aimed to improve treatment of neuropathic pain and mental health disorders.
Founded
obfuscation
PrivateSeries A Copenhagen, Hovedstaden, Denmark51-100 www.tetra-pharm.com/
Biotechnology
Mental Health
Precision Medicine
Overview

Tetra Pharm
Total Funding
obfuscation
Growth Score
24
Heat Score
3

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score24
4 pts
in past quarter
Heat Score 3
-35 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Tetra Pharm

CB Rank
117078
Tetra Pharm is aimed to improve treatment of neuropathic pain and mental health disorders.
Founded
obfuscation
PrivateSeries A Copenhagen, Hovedstaden, Denmark51-100 www.tetra-pharm.com/
Biotechnology
Mental Health
Precision Medicine

Funding Rounds

Series A
OBF
in
obfuscation

Details

Legal Name Tetra Pharm Technologies ApS
Also Known As Tetra Pharm Technologies
Operating Status Active
Company Type For Profit
About the Company
Tetra Pharm is aimed to research potential new drugs, creating fresh drug formulations, running clinical studies, and commercializing drugs that target the endocannabinoid system.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

XATEPA
A pharmaceutical drug released in Germany and the United Kingdom for pain relief.
TPT0301
A compound that has completed pre-clinical trial, potentially targeting chronic pain or mental health disorders.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Tetra Pharm Logo
Series A - Tetra Pharm
—
obfuscation
— Series A
obfuscation
Series A - Tetra Pharm Logo
Series A - Tetra Pharm
—
obfuscation
— Series A
obfuscation
Series A - Tetra Pharm Logo
Series A - Tetra Pharm
—
obfuscation
— Series A
obfuscation
Series A - Tetra Pharm Logo
Series A - Tetra Pharm
—
obfuscation
— Series A
obfuscation
Series A - Tetra Pharm Logo
Series A - Tetra Pharm
—
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Tetra Pharm Logo
Series A - Tetra Pharm
—
obfuscation
— Series A
obfuscation
Series A - Tetra Pharm Logo
Series A - Tetra Pharm
—
obfuscation
— Series A
obfuscation
Series A - Tetra Pharm Logo
Series A - Tetra Pharm
—
obfuscation
— Series A
obfuscation
Series A - Tetra Pharm Logo
Series A - Tetra Pharm
—
obfuscation
— Series A
obfuscation
Series A - Tetra Pharm Logo
Series A - Tetra Pharm
—
obfuscation
— Series A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Contacts 5
News

News and Press

News•Jan 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 18, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 30, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 29, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

5Tetra Pharm is actively using 5 technologies for its website, according to BuiltWith. These include DNSSEC, Danish Server Location, and  One.com DNS.

Total IP

17The intellectual property of Tetra Pharm includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Tetra Pharm has registered 13 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Tetra Pharm's headquarters? Tetra Pharm is located in Copenhagen, Hovedstaden, Denmark.When was the last funding round for Tetra Pharm? Tetra Pharm closed its last funding round on
obfuscation
from a Series A round.Who are Tetra Pharm's competitors? Alternatives and possible competitors to Tetra Pharm may include Tilray, Jazz Pharmaceuticals, and  Corbus Pharmaceuticals.How much funding has Tetra Pharm raised to date? Tetra Pharm has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|